Literature DB >> 2443505

Acute phase proteins in patients with abdominal aortic aneurysms.

J T Powell1, B R Muller, R M Greenhalgh.   

Abstract

Both stenosis and aneurysmal dilatation are associated with atherosclerosis of the distal aorta. As part of an investigation into factors predisposing to aneurysmal dilatation we compared the levels of acute phase proteins in patients with stenosing and aneurysmal disease. Increased levels of acute phase proteins were found in patients with abdominal aortic aneurysms compared with patients with stenosing aortic disease. In 20 aneurysm patients the C-reactive protein was 56 +/- 10 mg/l, alpha 1-proteinase inhibitor 2.5 +/- 0.13 g/l and ceruloplasmin 0.41 +/- 0.01 g/l. In 20 patients with stenosing aortic disease the C-reactive protein was 28 +/- 8 mg/l, alpha 1-proteinase inhibitor 1.65 +/- 0.11 g/l and ceruloplasmin 0.35 +/- 0.03 g/l. These results argue for the participation of an inflammatory process in the aortic wall in the pathogenesis of all aneurysms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443505

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  13 in total

Review 1.  Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation.

Authors:  Femke A M V I Hellenthal; Willem A Buurman; Will K W H Wodzig; Geert Willem H Schurink
Journal:  Nat Rev Cardiol       Date:  2009-06-23       Impact factor: 32.419

2.  Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm.

Authors:  Kin Lung Siu; Hua Cai
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

3.  Decreased plasma levels of ceruloplasmin after diet-induced weight loss in obese women.

Authors:  N Tajik; A Golpaie; S A Keshavarz; M Djalali; M Sehat; F Masoudkabir; Z Ahmadivand; F Fatehi; M Zare; T Yazdani
Journal:  J Endocrinol Invest       Date:  2011-07-27       Impact factor: 4.256

Review 4.  Genes and abdominal aortic aneurysm.

Authors:  Irene Hinterseher; Gerard Tromp; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2010-12-13       Impact factor: 1.466

5.  C-reactive protein/interleukin-6 ratio as marker of the size of the uncomplicated thoracic aortic aneurysms.

Authors:  Panagiotis Artemiou; Nicholas Charokopos; Efthymia Rouska; Frantisek Sabol; Ioannis Chrysogonidis; Vasiliki Tsavdaridou; Giannis Paschalidis
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-27

Review 6.  Circulating markers of abdominal aortic aneurysm presence and progression.

Authors:  Jonathan Golledge; Philip S Tsao; Ronald L Dalman; Paul E Norman
Journal:  Circulation       Date:  2008-12-02       Impact factor: 29.690

7.  Aortic dissection and third-degree atrioventricular block in a patient with a hypertensive crisis.

Authors:  Nikolaos Lionakis; Ioannis Moyssakis; Elias Gialafos; Nikolaos Dalianis; Vassilios Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738

Review 8.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06

9.  Systemic inflammation and repair of abdominal aortic aneurysm.

Authors:  Andrew L Tambyraja; Raymond Dawson; Domenico Valenti; John A Murie; Roderick T Chalmers
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

10.  Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population.

Authors:  Alberto Palazzuoli; Palazzuoli Alberto; Maddalena Gallotta; Gallotta Maddalena; Giuseppe Guerrieri; Guerrieri Giuseppe; Ilaria Quatrini; Quatrini Ilaria; Beatrice Franci; Maria Stella Campagna; Eugenio Neri; Neri Eugenio; Antonio Benvenuti; Benvenuti Antonio; Carlo Sassi; Sassi Carlo; Ranuccio Nuti; Nuti Ranuccio
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.